glp-1 and prostate cancer May Patients Receiving Agonists Be at Lower Risk of Aggressiveness Progression? Targeting obesity, metabolic syndrome, and

Patients considering GLP-1 receptor agonist or dual GIP/GLP-1 receptor agonist therapy should have an open discussion with their healthcare provider about personal and family cancer history

reported that in a diet-dependent mouse model, adropin 34-76 suppressed cAMP-activated protein kinase A activity and reduced the phosphorylation of inositol triphosphate receptor and element-binding protein

In particular, proximal tubular epithelial cells express CYP27B1, which converts circulating 25-hydroxyvitamin D [25(OH)D] into its biologically active form, 1,25-dihydroxyvitamin D [1,25(OH)D]

Tone: Apply Rose Water Hydrating Toner or Niacinamide Resurfacing Toner to balance pH and prime absorption

En el cerebro de los pacientes con AD, se sabe que la resistencia a la insulina dificulta el metabolismo de la glucosa y provoca un dficit de energa

T ocopherol (Vitamin E) is an antioxidant